Major Shareholding Notification • Oct 17, 2025
Major Shareholding Notification
Open in ViewerOpens in native device viewer
Updated 01.04.2019
The boxes in sections (1-6) and section (8) in the standard form must always be filled out.
Then, please fill out the sections in the standard form for the relevant type of financial instrument.
In case of proxy voting, fill out section (9) in the standard form.
| 1. Identity of the issueri : Zealand Pharma A/S (Sydmarken 11, DK-2860 Søborg, Denmark), CVR 20045078, LEI 549300ITBB1ULBL4CZ12) |
|||||
|---|---|---|---|---|---|
| 2. Reason for the notification (please tick the appropriate box or boxes): | |||||
| ✔ | An acquisition or disposal of voting rights or share capital | ||||
| An acquisition or disposal of financial instruments | |||||
| An event changing the breakdown of voting rights or share capital | |||||
| Other (please specify)ii: | |||||
| 3. Details of person subject to the notification obligationiii: | |||||
| Name: Mr. Adrianus van Herk |
Address: | Lichtenauerlaan 30, 3062 ME Rotterdam The Netherlands |
|||
| National ID-numberiv: | Email address: [email protected] |
||||
| 4. Full name of shareholder (if different from 3.)v : |
|||||
| Van Herk Investments B.V. (Chamber of Commerce 59055057) | |||||
| 5. Date on which the threshold was crossed or reachedvi: 15 October 2025 |
6.A Information on the issuer
| Voting rights: | |||
|---|---|---|---|
| Voting rights attached to shares in % (total of 7.1.A) |
Voting rights through financial instruments in % (total of 7.2.A + 7.3.B) |
Total of both in % (7.1.A + 7.2.A + 7.3.A) |
|
| Resulting situation on the date on which threshold was crossed or reached |
10,01% | 0,00% | 10,01% |
| Position of previous notification (if applicable) |
9,973% | 0,00% | 9,973% |
| Share capital: | |||
| Share capital attached to shares in % (total of 7.1.B) |
Share capital through financial instruments in % (total of 7.2.B + 7.3.B) |
Total of both in % (7.1.B + 7.2.B + 7.3.B) |
|
| Resulting situation on the date on which threshold was crossed or reached |
10,01% | 0,00% | 10,01% |
| Position of previous notification (if applicable) |
9,973% | 0,00% | 9,973% |
| 7.1.A: Voting rights attached to shares | |||||
|---|---|---|---|---|---|
| ISIN code | Number of voting rights | % of voting rights | |||
| Voting rights which the person subject to the notification obligation holds directly or indirectlyviii (Sect. 38(1) of the Capital Markets Act) |
Voting rights which the person subject to the notification obligation is entitled to acquire, dispose of or exercise (Sect. 38(2) of the Capital Markets Act) |
Voting rights which the person subject to the notification obligation holds directly or indirectlyviii (Sect. 38(1) of the Capital Markets Act) |
Voting rights which the person subject to the notification obligation is entitled to acquire, dispose of or exercise (Sect. 38(2) of the Capital Markets Act) |
||
| DK0060257814 | 7,143,305 | 10,01% | |||
| SUBTOTAL 7.1.A | 7,143,305 | 10,01% | |||
| 7.1.B: Share capital attached to shares | |||||
| ISIN code | Number of sharesviii | % of shares | |||
| (Sect. 38(1) of the Capital Markets Act) | (Sect. 38(1) of the Capital Markets Act) | ||||
| DK0060257814 | 7,143,305 | 10,01% | |||
| SUBTOTAL 7.1.B | 7,143,305 | 10,01% |
| 7.2 Financial instruments according to section 39(2)(1) of the Capital Markets Act | |||||
|---|---|---|---|---|---|
| 7.2.A: Voting rights attached to financial instruments according to section 39(2)(1) of the Capital Markets Act | |||||
| Type of financial instrument |
Expiration date ix |
Exercise/conversion periodx |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights | |
| SUBTOTAL 7.2.A |
| Type of financial instrument |
Expiration date ix |
Exercise/conversion periodx |
Number of shares that may be acquired if the instrument is exercised/converted |
% of share capital |
|---|---|---|---|---|
| SUBTOTAL 7.2.B |
| 7.3 Financial Instruments with similar economic effect acc. to sect. 39(2)(2) of the Capital Markets Act | |||||
|---|---|---|---|---|---|
| 7.3.A: Voting rights attached to financial instruments according to section 39(2)(2) of the Capital Markets Act | |||||
| Type of financial instrument |
Expiration dateix |
Exercise/conversion periodx |
Physical or cash settlementxi |
Number of voting rights |
% of voting rights |
| SUBTOTAL 7.3.A |
| 7.3.B: Share capital attached to financial instruments according to section 39(2)(2) of the Capital Markets Act | |||||
|---|---|---|---|---|---|
| Type of financial instrument |
Expiration dateix |
Exercise/conversion periodx |
Physical or cash settlementxi |
Number of shares |
% of share capital |
| SUBTOTAL 7.3.B |
| 8. Chain of controlled undertakings (please tick the appropriate box): | |||||||
|---|---|---|---|---|---|---|---|
| The person subject to the notification obligation is not controlled by any natural person or legal entity and does not |
|||||||
| xii control any undertaking(s) with holdings in the (underlying) issuer .xii |
|||||||
| ✔ |
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are | ||||||
| effectively held starting with the ultimate controlling natural person or legal entity : | xiii | ||||||
| Namexiv | Total voting rights if more than 5% | Total share capital if more than | |||||
| 5% | |||||||
| Mr. A. van Herk | 10,01% | 10,01% | |||||
| Van Herk Private Equity Investments B.V. | 10,01% | 10,01% | |||||
| Van Herk Investments THI B.V. | 10,01% | 10,01% | |||||
| Van Herk Investments B.V. | 10,01% | 10,01% | |||||
| 9. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of | |||||||
| [date] |
| 10. Additional informationxv: |
|---|
Van Herk Investments B.V. is being controlled by Van Herk Management Services B.V. and will notify its voting right in a separate notification.
Date, place and signature
16 October 2025, Rotterdam Signed by E.G.A. Esveld
As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party), the standard form does not provide for a specific method on how to notify cases of acting in concert.
In relation to the transactions referred to in sentences (2) to (8) of section 38(2) of the Capital Markets Act, the following list is provided as indication of the persons who should be mentioned:
i Full name of the issuer. With regard to financial instruments by issuer means the issuer of the underlying share.
ii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiry of financial instruments) or acting in concert.
iii This should be the full name of
iv National identification number of the natural person or legal entity if such exists.
v Applicable in the cases provided for in section 38(2)(2-8) of the Capital Markets Act. This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to in section 38(2) of that Act unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).
vi The date on which a threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.
In case of multiple chains through which the voting rights and/or financial instruments are effectively held, the chains have to be presented chain by chain leaving a row free between different chains (e.g.: A, B, C, free row, A, B, D, free row, A, E, F etc.).
Have a question? We'll get back to you promptly.